Characterization of aqueous dispersions of Fe(3)O(4) nanoparticles and their biomedical applications.

A newly developed non-polymer coated Fe(3)O(4) nanoparticles showing well-dispersion were synthesized using Fe(II) and Fe(III) salt chemical coprecipitation with tetramethylammonium hydroxide (N(CH(3))(4)OH) in an aqueous solution. Transmission electron microscopy (TEM), X-ray diffraction (XRD), Fourier transform infrared spectrometer (FT-IR), X-ray photoelectron spectrometer (XPS) and superconducting quantum interference measurement device (SQUID) measurements were employed to investigate the iron oxide properties. The resulting iron oxide particles were manipulated to be as small as 9 nm diameter in size. Based on FT-IR and X-ray photoelectron spectrometer results, it is suggested that the surfaces of the magnetite (Fe(3)O(4)) particles are covered with hydroxide (-OH) groups incorporated with (CH(3))(4)N(+) through electrostatic interaction. The in vitro cytotoxicity test revealed that the magnetite particles exhibited excellent biocompatibility, suggesting that they may be further explored for biomedical applications. NMR measurements revealed significantly reduced water proton relaxation times T1 and T2. The MR images of the nanoparticles in water, serum, and whole blood were investigated using a 1.5 T clinical MR imager. Significant reduction of the background medium signal was achieved in the T2-weighted and the T2*-weighted sequence especially in the serum and whole blood. Combining the advantage of MRI signal contrast, the non-polymer-coated surface chemistry for distinct bioconjugation and the homogenous nanometer size for better controlled biodistribution, these preliminary experiments demonstrated the potential of the as-synthesized magnetite material in functional molecular imaging for biomedical research and clinical diagnosis.

[1]  P. Bunn,et al.  Synthesis and evaluation of colloidal magnetic iron oxides for the site-specific radiofrequency-induced hyperthermia of cancer , 1993 .

[2]  B. Hamm,et al.  Coronary MR angiography: experimental results with a monomer-stabilized blood pool contrast medium. , 2002, Radiology.

[3]  B. Hamm,et al.  Preclinical characterization of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as a blood pool contrast medium for MR angiography. , 2002, Academic radiology.

[4]  W. L. Jolly,et al.  Nitrogen 1s binding energies of transition metal nitrosyls , 1972 .

[5]  A. Olukotun,et al.  Phase I clinical evaluation of a new iron oxide MR contrast agent , 1994, Journal of magnetic resonance imaging : JMRI.

[6]  R. W. Linton,et al.  Chemical characterization of hydrous ferric oxides by x-ray photoelectron spectroscopy , 1981 .

[7]  Pieter Stroeve,et al.  Synthesis and Characterization of Nanometer-Size Fe3O4 and γ-Fe2O3 Particles , 1996 .

[8]  Nathan Kohler,et al.  Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. , 2002, Biomaterials.

[9]  C. Beigelman,et al.  Iron oxide-enhanced MR lymphography: initial experience. , 2000, European journal of radiology.

[10]  P. Reimer,et al.  Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications , 2003, European Radiology.

[11]  R Weissleder,et al.  Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. , 1988, Radiology.

[12]  P Reichardt,et al.  Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. , 1996, Cancer research.

[13]  Peter Wust,et al.  Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro , 1999 .

[14]  S. Mann,et al.  Formation of iron oxides in unilamellar vesicles , 1988 .

[15]  M. Muhammed,et al.  Synthesis and characterization of surfactant-coated superparamagnetic monodispersed iron oxide nanoparticles , 2001 .

[16]  C. W. Jung Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. , 1995, Magnetic resonance imaging.

[17]  R. Müller,et al.  A Novel Formulation for Superparamagnetic Iron Oxide (SPIO) Particles Enhancing MR Lymphography: Comparison of Physicochemical Properties and The In Vivo Behaviour , 2002, Journal of drug targeting.

[18]  L. Vander Elst,et al.  Recent developments in design, characterization, and understanding of MRI and MRS contrast media. , 1990, Investigative radiology.

[19]  W. Semmler,et al.  The influence of the sample preparation on plasma protein adsorption patterns on polysaccharide-stabilized iron oxide particles and N-terminal microsequencing of unknown proteins. , 1997, Journal of drug targeting.

[20]  H. Hertz,et al.  VM‐26 (Teniposide)-Induced Hypersensitivity and Degranulation of Basophils in Children , 1988, The American journal of pediatric hematology/oncology.

[21]  M. Saunders,et al.  Magnetite Nanoparticle Dispersions Stabilized with Triblock Copolymers , 2003 .

[22]  V. Dravid,et al.  Self-assembled (SA) bilayer molecular coating on magnetic nanoparticles , 2001 .

[23]  Abraham Ulman,et al.  Activity of Candida rugosa lipase immobilized on gamma-Fe2O3 magnetic nanoparticles. , 2003, Journal of the American Chemical Society.

[24]  Bernd Hamm,et al.  Monomer-Coated Very Small Superparamagnetic Iron Oxide Particles as Contrast Medium for Magnetic Resonance Imaging: Preclinical In Vivo Characterization , 2002, Investigative radiology.

[25]  E. Knittle,et al.  An XAFS study of the crystal chemistry of Fe in orthopyroxene , 1996 .

[26]  W. Lorenz,et al.  Modulation of histamine release from rat peritoneal mast cells by non-cytotoxic concentrations of the detergents Cremophor El® (oxethylated castor oil) and Triton X100. A possible explanation for unexpected adverse drug reactions? , 1986, Agents and Actions.

[27]  S. Contarini,et al.  X‐Ray Photoelectron Spectroscopic Studies of Metal/Inhibitor Systems: Structure and Bonding at the Iron/Amine Interface , 1989 .

[28]  T. A. Hatton,et al.  Bilayer Surfactant Stabilized Magnetic Fluids: Synthesis and Interactions at Interfaces , 1999 .

[29]  Yang,et al.  Magnetite Nanoparticles Prepared by Precipitation from Partially Reduced Ferric Chloride Aqueous Solutions. , 1999, Journal of colloid and interface science.

[30]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.

[31]  Hao Zeng,et al.  Size-controlled synthesis of magnetite nanoparticles. , 2002, Journal of the American Chemical Society.

[32]  B. Bonnemain,et al.  Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review. , 1998, Journal of drug targeting.

[33]  R. Weisskoff,et al.  Dynamic signal intensity changes in liver with superparamagnetic MR contrast agents , 1992, Journal of magnetic resonance imaging : JMRI.

[34]  A. Gedanken,et al.  Sonochemical synthesis and characterization of pure nanometer-sized Fe3O4 particles , 2000 .

[35]  R. Weissleder,et al.  Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors. , 1990, Radiology.

[36]  I. Lucet,et al.  Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. , 1996, Journal of microencapsulation.

[37]  Robert E. Lenkinski,et al.  Gadolinium-Loaded Nanoparticles: New Contrast Agents for Magnetic Resonance Imaging , 2000 .

[38]  C. Bergemann,et al.  Magnetic ion-exchange nano- and microparticles for medical, biochemical and molecular biological applications , 1999 .

[39]  U. Schwertmann,et al.  The Iron Oxides: Structure, Properties, Reactions, Occurrences and Uses , 2003 .

[40]  B Hamm,et al.  New generation of monomer‐stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: Preclinical results in rats and rabbits , 2000, Journal of magnetic resonance imaging : JMRI.

[41]  Mamoun Muhammed,et al.  Characterization and MRI study of surfactant-coated superparamagnetic nanoparticles administered into the rat brain , 2001 .